Biomarkers of Radioresistance in Head and Neck Cancer: A New Beginning

The development of biomarkers of radioresistance in head and neck cancer may help personalize treatment. This commentary puts in context the findings of a secondary analysis of NRG/RTOG 9512, a trial of fractionation in T2N0 glottic cancer, which observed that NFE2L2/KEAP1/CUL3 mutations are correlated with local recurrence and disease-free survival. See related article by Guan et al., p. 1615.

Authors

Yuan James Rao (ORCID: https://orcid.org/0000-0002-9938-2197)

Institutions

George Washington University (US)

Publication Details

Journal: Clinical Cancer Research
Published: 2025-02-18
DOI: https://doi.org/10.1158/1078-0432.ccr-24-4223
Primary Topic: Lung Cancer Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Biomarkers of Radioresistance in Head and Neck Cancer: A New Beginning

Yuan James Rao

Feb 18, 2025

Clinical Cancer Research

Lung Cancer Research Studies

article

Biomarkers of Radioresistance in Head and Neck Cancer: A New Beginning

Yuan James Rao

February 18, 2025article en

Abstract

Clinical Cancer ResearchVol. 31(9)

George Washington University (US)

Good health and well-being

Openalex Percentile: Top 96%

Lung Cancer Research Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Biomarkers of Radioresistance in Head and Neck Cancer: A New Beginning — Yuan James Rao · Clinical Cancer Research (2025) | TGRS Research Map | TGRS